Funding & Networks

Current Funding

2023-2025: Boehringer-Ingelheim Stiftung Exploration grant, SuperFluorophores.

2022-2024: Boehringer-Ingelheim Stiftung Exploration grant, High-precision enzyme activity imaging in vivo.

2019-2024: DFG SPP1926 Next Generation Optogenetics Network: project High-performance photoswitches for biology (with K. Lang & M. Sumser).

2018-2025: DFG Emmy Noether group, Chemical approaches for characterising and controlling physiological microtubule composition and dynamics.

Reagent Development

As of 2024, we have delivered our photoswitchable microtubule inhibitor reagents (PST, SBTub, CouEpo famillies) to around 250 research groups around the world for applications in embryonic development, cell biology, and neuroscience. We recently started distributing our oxidoreductase imaging probes (RX1 probe for TrxR1, S6 probes for dithiol reductases), and our dichalcogenide linker/adapter library, to the redox community.

Completed Grants in the Group

2017-2024: DFG SFB1032 "Nanoagents for Spatiotemporal Control" cluster project B09, Photoswitchable reagents for control of biological function.
2018-2022: DFG SFB152 “TRiPs to Homeostasis” cluster project P24, Photoresponsive reagents for modulating TRP channel function.
2019-2022: BMBF GO-Bio spinoff grant: Tumour Targeting of Nanoparticles (NanoCapture project). Previously supported by BMBF Innovation Biotechnologie Expansion grant (2017 – 2019) and BMBF Proof of Concept grant (2016 – 2017).
2020: The LMUExcellent Junior Researcher Fund supported our Probes for Redox Biology research programme.
2017-2020: BMWi EXIST-FT spinoff grant: Photopharmaceuticals for Cancer Therapy (CytoSwitch project). Previously supported by the Bavarian FLÜGGE program (2016-2017).